Vertex Ventures joins $47.6m Series A round in US-based Palleon Pharma

Vertex Ventures joins $47.6m Series A round in US-based Palleon Pharma

Vertex Ventures. Photographer: Sam Kang Li/Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter